Acute or chronic hepatitis or other liver disease (excluding nonalcoholic fatty liver diseased) or ALT level > 3× ULN for the reference range, ALP level > 1.5× ULN, or total bilirubin > 1.5× ULN, except for Gilbert's syndrome. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.